Novel peptides secreted from human neuroblastoma: useful clinical tools?

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Pediatric Surgery

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.JPEDSURG.2005.10.048PMID 16410142
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synaptophysin--an immuno-histochemical marker for childhood neuroblastoma.

  2009cited by this paper
• The biologic basis for neuroblastoma heterogeneity and risk stratification

  2005cited by this paper
• Quantitative analysis of free ubiquitin and multi-ubiquitin chain in colorectal cancer.

  2004cited by this paper
• Ubiquilin-1 is a novel HASH-1-complexing protein that regulates levels of neuronal bHLH transcription factors in human neuroblastoma cells.

  2004cited by this paper
• [Does beta-2 microglobulin measurement play role in diagnostics of childhood malignancies?].

  2004cited by this paper
• Advancement of Biomarker Discovery and Validation through the HUPO Plasma Proteome Project

  2004cited by this paper
• Radically Different Treatment Recommendations for Newly Diagnosed Neuroblastoma: Pitfalls in Assessment of Risk

  2004cited by this paper
• A critical review of vascular endothelial growth factor (VEGF) analysis in peripheral blood: Is the current literature meaningful?

  2004cited by this paper
• The Cu,Zn superoxide dismutase in neuroblastoma SK-N-BE cells is exported by a microvesicles dependent pathway.

  2003cited by this paper
• Increased Activity of Catalase in Tumor Cells Overexpressing IGFBP-2

  2003cited by this paper
• Proteins and proteomics : a laboratory manual

  2003cited by this paper
• Serum ubiquitin levels in patients with nonalcoholic steatohepatitis.

  2003cited by this paper
• Current Clinical Trials in Neuroblastoma

  2002cited by this paper
• Clinical trials referral resource. Current clinical trials in neuroblastoma.

  2002cited by this paper
• Age-dependent levels of plasma neuropeptides in normal children.

  2002cited by this paper
• Galanin and galanin receptor expression in neuroblastic tumours: correlation with their differentiation status

  2002cited by this paper
• Higher oxidation and lower antioxidant levels in peripheral blood plasma and bone marrow plasma from advanced cancer patients

  2002cited by this paper
• Ubiquitin-binding protein p62 expression is induced during apoptosis and proteasomal inhibition in neuronal cells.

  2001cited by this paper
• Nuclear translocation and aggregate formation of heat shock cognate protein 70 (Hsc70) in oxidative stress and apoptosis.

  2000cited by this paper
• The ubiquitin system

  2000cited by this paper
• Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase

  2000cited by this paper
• Protein identification at the low femtomole level from silver-stained gels using a new fritless electrospray interface for liquid chromatography-microspray and nanospray mass spectrometry.

  1998cited by this paper
• Secretion and increase of intracellular CuZn superoxide dismutase content in human neuroblastoma SK-N-BE cells subjected to oxidative stress.

  1998cited by this paper
• The ubiquitin system.

  1998cited by this paper
• Increased ubiquitin immunoreactivity in hepatocellular carcinomas and precancerous lesions of the liver.

  1997cited by this paper
• Somatostatin in neuroblastoma and ganglioneuroma.

  1997cited by this paper
• Neuroblastoma and insulin-like growth factor system

  1997cited by this paper
• Neuroblastoma and insulin-like growth factor system. New insights and clinical perspectives.

  1997cited by this paper
• A comparative analysis of neuroblastic and substrate-adherent human neuroblastoma cell lines.

  1996cited by this paper
• Removal of serum from primary cultures of cerebellar granule neurons induces oxidative stress and DNA fragmentation: Protection with antioxidants and glutamate receptor antagonists

  1996cited by this paper
• Plasma levels of chromogranin A are directly proportional to tumour burden in neuroblastoma.

  1996cited by this paper
• Expression of IGFBP-2, -3, and -4 mRNA during differentiation of Caco-2 colon epithelial cells.

  1996cited by this paper
• Insulin-like growth factor-binding protein-2 and -3 expression in benign human prostate epithelium, prostate intraepithelial neoplasia, and adenocarcinoma of the prostate.

  1996cited by this paper
• Pituitary adenylate cyclase activating peptide and its receptors are expressed in human neuroblastomas

  1996cited by this paper
• Chapter 18 Neuropeptides in neuroblastomas and ganglioneuromas

  1995cited by this paper
• Differential expression of pleiotrophin and midkine in advanced neuroblastomas.

  1995cited by this paper
• Pancreastatin immunoreactivity in favourable childhood neuroblastoma and ganglioneuroma.

  1995cited by this paper
• Somatostatin and vasoactive intestinal peptide (VIP) in neuroblastoma and ganglioneuroma: chromatographic characterisation and release during surgery.

  1995cited by this paper
• Serum β–carotene, vitamin E, vitamin C and malondialdehyde levels in several types of cancer

  1995cited by this paper
• Neuropeptides in neuroblastomas and ganglioneuromas.

  1995cited by this paper
• A radioimmunoassay for the quantification of human ubiquitin in biological fluids: application to parasitic and allergic diseases.

  1994cited by this paper
• Diet and oxidative stress in breast, colon and prostate cancer patients: a case-control study.

  1994cited by this paper
• Neuropeptide Y in neuroblastoma: increased concentration in metastasis, release during surgery, and characterization of plasma and tumor extracts.

  1993cited by this paper
• Activation of apoptosis by serum deprivation in a teratocarcinoma cell line: inhibition by L-acetylcarnitine.

  1993cited by this paper
• Increase in plasma concentration of ubiquitin in dialysis patients: possible involvement in beta 2-microglobulin amyloidosis.

  1993cited by this paper
• IGFBP-2: an important regulator of insulin-like growth factor action in human lung tumours?

  1993cited by this paper
• The chromogranins A and B: The first 25 years and future perspectives

  1992cited by this paper
• Marked increase in cerebrospinal fluid ubiquitin in Creutzfeldt-Jakob disease.

  1992cited by this paper
• Distinct regulation of vasoactive intestinal peptide (VIP) expression at mRNA and peptide levels in human neuroblastoma cells.

  1992cited by this paper
• Production of insulin-like growth factor-binding proteins by human central nervous system tumors.

  1991cited by this paper
• Identification of insulin-like growth factor binding proteins in breast cancer cells

  1991cited by this paper
• Production of large amounts of hydrogen peroxide by human tumor cells.

  1991cited by this paper
• Changes in expressions of proteasome and ubiquitin genes in human renal cancer cells.

  1991cited by this paper
• Neuropeptide Y as a marker in pediatric neuroblastoma.

  1990cited by this paper
• Clinical trials referral resource.

  1990cited by this paper
• MHC regulation in neural cells. Distribution of peripheral and internal beta 2-microglobulin and class I molecules in human neuroblastoma cell lines.

  1990cited by this paper
• Beta 2-microglobulin expression in human embryonal neuroblastoma reflects its developmental regulation.

  1990cited by this paper
• Atrial natriuretic peptide in human neuroblastoma.

  1989cited by this paper
• The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase.

  1989cited by this paper
• Expression of the proenkephalin gene in human neuroblastoma cell lines.

  1988cited by this paper
• Markers for neuroendocrine differentiation.

  1988cited by this paper
• Markers for Neuroendocrine Differentation

  1988cited by this paper
• Co-existence and co-secretion of the structurally related peptides VIP and PHI.

  1987cited by this paper
• PGP 9.5, a new marker for human neuroendocrine tumours

  1985cited by this paper
• VASOACTIVE INTESTINAL POLYPEPTIDE (VIP) IN CHILDREN WITH NEURAL CREST TUMOURS

  1982cited by this paper
• Neuron-specific enolase is produced by neuroendocrine tumours.

  1981cited by this paper
• Letter: Diabetogenic drugs.

  1976cited by this paper

• Gene Expression and Early Radiation Response of Two Distinct Neuroblastoma Cell Lines

  2023cites this paper
• HSP70 and HSP90 in Cancer: Cytosolic, Endoplasmic Reticulum and Mitochondrial Chaperones of Tumorigenesis

  2022cites this paper
• Targeted Imaging Agent to HSP70 Induced In Vivo

  2020cites this paper
• Dose Dependent Synergism from Combination of Platinum Drugs with Curcumin Sgainst Colorectal Cancer Cell Lines

  2020cites this paper
• Overexpression of Hsc70 promotes proliferation, migration, and invasion of human glioma cells

  2019cites this paper
• Heat Shock Protein 70 and Cancer

  2018cites this paper
• Heat Shock Proteins and Cancer.

  2017cites this paper
• Recent advances in in vitro fertilization

  2017cites this paper
• Zinc and zinc-containing biomolecules in childhood brain tumors

  2016cites this paper
• IGF-Binding Protein 2 – Oncogene or Tumor Suppressor?

  2015cites this paper
• Diagnostic Techniques to Improve the Assessment of Human IVF Embryos: Genomics and Proteomics

  2014cites this paper
• Gamete and Embryo Selection

  2014cites this paper
• Intact protein analysis of ubiquitin in cerebrospinal fluid by multiple reaction monitoring reveals differences in Alzheimer's disease and frontotemporal lobar degeneration.

  2014cites this paper
• RECENT ADVANCES IN IN VITRO FERTILIZATION: PROTEOMICS, SECRETOMICS, METABOLOMICS AND IN VITRO MATURATION

  2013cites this paper
• Embryology in the era of proteomics.

  2013cites this paper
• Proteomic Analysis of Embryo Viability

  2013cites this paper
• Mass spectrometry identification of granins and other proteins secreted by neuroblastoma cells

  2013cites this paper
• Application of Proteomics to Soft Tissue Sarcomas

  2012cites this paper
• Comprehensive review on the HSC70 functions, interactions with related molecules and involvement in clinical diseases and therapeutic potential.

  2012cites this paper
• Evaluation of embryo quality: Proteomic strategies

  2012cites this paper
• Proteomic/Metabolomic Analysis of Embryos: Current Status for Use in ART

  2011cites this paper
• The SODyssey: superoxide dismutases from biochemistry, through proteomics, to oxidative stress, aging and nutraceuticals

  2011cites this paper
• The serum levels of soluble interleukin-2 receptor α and lactate dehydrogenase but not of B2-microglobulin correlate with selected clinico-pathological prognostic factors and response to therapy in childhood soft tissue sarcomas

  2010cites this paper
• Oncoproteomics of Neuroblastoma: A Blueprint for Future Progress

  2010cites this paper
• Proteomic approaches in neuroblastoma: a complementary clinical platform for the future

  2009cites this paper
• The role of proteomics in defining the human embryonic secretome

  2009cites this paper
• Proteomic analysis of neuroblastoma microenvironment: effect of the host-tumor interaction on disease progression.

  2009cites this paper
• Three-dimensional neuroblastoma cell culture: proteomic analysis between monolayer and multicellular tumor spheroids

  2008cites this paper
• Oxidative status in neuroblastoma: a source of stress?

  2008cites this paper
• Serum protein profiling to identify high-risk neuroblastoma: preclinical relevance of blood-based biomarkers.

  2007cites this paper
• Efficient high-throughput discovery of large peptidic hormones and biomarkers.

  2006cites this paper
• Proteomic analysis of neuroblastoma subtypes in response to mitogen-activated protein kinase inhibition: profiling multiple targets of cancer kinase signaling.

  2006cites this paper
• Neuroblastoma detection using serum proteomic profiling: a novel mining technique for cancer?

  2006cites this paper